TGF-β has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines

Growth Factors

Volumn 26, Issue 5, 2008, Pages 254-262

  Muñoz, Nina M ^a,b   Baek, Ji Yeon ^b,c   Grady, William M ^a,b,d  

^a VANDERBILT UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c The Catholic University of Korea   (South Korea)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Anoikis; Apoptosis; Colorectal cancer; Transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANOIKIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANOIKIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CULTURE MEDIA, SERUM-FREE; GENES, REPORTER; HCT116 CELLS; HUMANS; LUCIFERASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 52649089211     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802291667     Document Type: Article

References (47)

1. Alazzouzi, H., Alhopuro, P., Salovaara, R., Sammalkorpi, H., Jarvinen, H., Mecklin, J-P, Hemminki, A., Schwartz Jr., S., Aaltonen, LA and Arango, D. (2005) SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res, 11:7, pp. 2606-2611.
2. Alhopuro, P., Alazzouzi, H., Sammalkorpi, H., Davalos, V., Salovaara, R., Hemminki, A., Jarvinen, H., Mecklin, JP, Schwartz Jr., S. Aaltonen, LA et al. (2005) SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res, 11:17, pp. 6311-6316.
3. Biswas, S., Chytil, A., Washington, K., Romero-Gallo, J., Gorska, AE, Wirth, PS, Gautam, S., Moses, HL and Grady, WM (2004) Transforming growth factor b receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res, 64:14, pp. 4687-4692.
4. Boisvert-Adamo, K. and Aplin, AE (2006) B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene, 25:35, pp. 4848-4856.
5. Boulay, JL, Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U., Herrmann, R. and Rochlitz, C. (2002) SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer, 87:6, pp. 630-634.
6. Derynck, R., Akhurst, RJ and Balmain, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet, 29:2, pp. 117-129.
7. Douma, S., VanLaar, T., Zevenhoven, J., Meuwissen, R., VanGarderen, E. and Peeper, D. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature, 430:7003, pp. 1034-1039.
8. Duxbury, MS, Ito, H., Zinner, MJ, Ashley, SW and Whang, EE (2004) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene, 23:2, pp. 465-473.
9. Duxbury, MS, Ito, H., Zinner, MJ, Ashley, SW and Whang, EE (2004) Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery, 135:5, pp. 555-562.
10. Elliott, RL and Blobe, GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol, 23:9, pp. 2078-2093.
11. Engle, S., Hoying, J., Boivin, G., Ormsby, I., Gartside, P. and Doetschman, T. (1999) Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage in tumorigenesis. Cancer Res, 59, pp. 3379-3386.
12. Engle, SJ, Ormsby, I., Pawlowski, S., Boivin, GP, Croft, J., Balish, E. and Doetschman, T. (2002) Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res, 62:22, pp. 6362-6366.
13. Eppert, K., Scherer, S., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C, Bapat, B., Gallinger, S. Andrulis, I. et al. (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal cancer. Cell, 86, pp. 543-552.
14. Fernandez, Y., Gu, B., Martinez, A., Torregrosa, A. and Sierra, A. (2002) Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state. Int J Cancer, 101:4, pp. 317-326.
15. Frisch, SM and Francis, H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124:4, pp. 619-626.
16. Frisch, SM and Screaton, RA (2001) Anoikis mechanisms. Curr Opin Cell Biol, 13:5, pp. 555-562.
17. Gorska, AE, Jensen, RA, Shyr, Y., Aakre, ME, Bhowmick, NA and Moses, HL (2003) Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol, 163:4, pp. 1539-1549.
18. Gorska, AE, Joseph, H., Derynck, R., Moses, HL and Serra, R. (1998) Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ, 9:3, pp. 229-238.
19. Grady, WM, Myeroff, LL, Swinler, SE, Rajput, A., Thiagalingam, S., Lutterbaugh, JD, Neumann, A., Brattain, MG, Chang, J. Kim, S-J et al. (1999) Mutational inactivation of transforming growth factor-beta receptor type II in microsatellite stable colon cancers. Cancer Res, 59:2, pp. 320-324.
20. Grossmann, J. (2002) Molecular mechanisms of "detachment-induced apoptosis - Anoikis". Apoptosis, 7:3, pp. 247-260.
21. Hahn, S., Schutte, M., Shamsul Hoque, A, Moskaluk, C., da Costa, L., Rozenblum, E., Weinstein, C., Fischer, A., Yeo, C. Hruban, R. et al. (1996) DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science, 271, pp. 350-353.
22. Jung, B., Smith, E., Doctolero, R., Gervaz, P., Alonso, J., Miyai, K., Keku, T., Sandler, R. and Carethers, J. (2006) Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer, 118:10, pp. 2509-2513.
23. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, PH and Downward, J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. Embo J, 16:10, pp. 2783-2793.
24. Koi, M., Umar, A., Chauhan, DP, Cherian, SP, Carethers, JM, Kunkel, TA and Boland, CR (1995) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation [published erratum appears in Cancer Res 1995 Jan 1;55(1):201]. Cancer Res, 54:16, pp. 4308-4312.
25. Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman-Roman, S., Cherqui, G. and Atfi, A. (2001) Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene, 20:7, pp. 879-884.
26. Massague, J. (1998) TGF-β signal transduction. Annu Rev Biochem, 67:1, pp. 753-791.
27. Muraoka-Cook, RS, Kurokawa, H., Koh, Y., Forbes, JT, Roebuck, LR, Barcellos-Hoff, MH, Moody, SE, Chodosh, LA and Arteaga, CL (2004) Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res, 64:24, pp. 9002-9011.
28. Normanno, N., De Luca, A., Maiello, MR, Bianco, C., Mancino, M., Strizzi, L., Arra, C., Ciardiello, F., Agrawal, S. and Salomon, DS (2004) CRIPTO-1: A novel target for therapeutic intervention in human carcinoma. Int J Oncol, 25:4, pp. 1013-1020.
29. Oft, M., Heider, KH and Beug, H. (1998) TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol, 8:23, pp. 1243-1252.
30. Parsons, R., Myeroff, LL, Liu, B., Willson, JK, Markowitz, SD, Kinzler, KW and Vogelstein, B. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res, 55:23, pp. 5548-5550.
31. Pierce, D., Gorska, A., Chytil, A., Meise, K., Page, D., Coffey, R. and Moses, H. (1995) Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci USA, 92, pp. 4254-4258.
32. Prehn, JHM, Bindokas, VP, Marcuccilli, CJ, Krajewski, S., Reed, JC and Miller, RJ (1994) Regulation of neuronal Bc12 protein expression and calcium homeostasis by transforming growth factor type {beta} confers wide-ranging protection on rat hippocampal neurons. PNAS, 91:26, pp. 12599-12603.
33. Ramachandra, M., Atencio, I., Rahman, A., Vaillancourt, M., Zou, A., Avanzini, J., Wills, K., Bookstein, R. and Shabram, P. (2002) Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis. Cancer Res, 62:21, pp. 6045-6051.
34. Samowitz, WS, Curtin, K., Neuhausen, S., Schaffer, D. and Slattery, ML (2002) Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosomes Cancer, 35:4, pp. 368-371.
35. Sanchez-Capelo, A. (2005) Dual role for TGF-[beta]1 in apoptosis. Cytokine Growth Factor Rev, 16:1, pp. 15-34.
36. Schlapbach, R., Spanaus, KS, Malipiero, U., Lens, S., Tasinato, A., Tschopp, J. and Fontana, A. (2000) TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur J Immunol, 30:12, pp. 3680-3688.
37. Schulze, A., Lehmann, K., Jefferies, HB, McMahon, M. and Downward, J. (2001) Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev, 15:8, pp. 981-994.
38. Schutte, M., Hruban, R., Hedrick, L., Cho, K., Nadasdy, G., Weinstein, C., Bova, G., Isaacs, W., Cairns, P. Nawroz, H. et al. (1996) DPC4 gene in various tumor types. Cancer Res, 56, pp. 2527-2530.
39. Shimanuki, T., Hara, T., Furuya, T., Imamura, T. and Miyazono, K. (2007) Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. Oncogene, 26:23, pp. 3311-3320.
40. Shin, I., Bakin, AV, Rodeck, U., Brunet, A. and Arteaga, CL (2001) Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell, 12:11, pp. 3328-3339.
41. Siegel, P. and Massague, J. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer, 3:11, pp. 807-821.
42. Swift, LL, Farkas, MH, Major, AS, Valyi-Nagy, K., Linton, MF and Fazio, S. (2001) A recycling pathway for resecretion of internalized apolipoprotein E in liver cells. J Biol Chem, 276:25, pp. 22965-22970.
43. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. and Taketo, M. (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell, 92, pp. 645-656.
44. Watanabe, T., Wu, T-T, Catalano, PJ, Ueki, T., Satriano, R., Haller, DG, Benson, AB and Hamilton, SR (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med, 344:16, pp. 1196-1206.
45. Yawata, A., Adachi, M., Okuda, H., Naishiro, Y., Takamura, T., Hareyama, M., Takayama, S., Reed, JC and Imai, K. (1998) Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene, 16:20, pp. 2681-2686.
46. Zhu, Y., Richardson, J., Parada, L. and Graff, J. (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell, 94, pp. 703-714.
47. Zhu, Z., Sanchez-Sweatman, O., Huang, X., Wiltrout, R., Khokha, R., Zhao, Q. and Gorelik, E. (2001) Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res, 61:4, pp. 1707-1716.